Basel Medical Group Ltd (NASDAQ:BMGL) Stock Short Interest Jumps 1,917.0%

Posted by Teresa Graham on Sep 24th, 2026

Basel Medical Group Ltd (NASDAQ:BMGL – Get Free Report) was the recipient of a significant growth in short interest during the month of September. As of September 15th, there was short interest totaling 159,585 shares, a growth of 1,917.0% from the August 31st total of 7,912 shares. Based on an average trading volume of 3,135,507 shares, the short-interest ratio is currently 0.1 days. Approximately 10.1% of the company’s shares are short sold.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings cut Basel Medical Group from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Tuesday, September 8th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock currently has a consensus rating of “Sell”.

View Our Latest Report on BMGL

Basel Medical Group Stock Performance

Shares of BMGL stock traded down $0.29 during trading hours on Thursday, hitting $3.80. The company had a trading volume of 61,502 shares, compared to its average volume of 209,493. The company’s fifty day moving average is $5.20 and its 200 day moving average is $6.57. The company has a debt-to-equity ratio of 0.93, a quick ratio of 1.83 and a current ratio of 1.88. Basel Medical Group has a fifty-two week low of $3.70 and a fifty-two week high of $22.20.

Basel Medical Group (NASDAQ:BMGL – Get Free Report) last posted its quarterly earnings data on Friday, June 26th. The company reported $0.01 earnings per share for the quarter. The company had revenue of $3.21 million for the quarter.

About Basel Medical Group

(Get Free Report)

Basel Medical Group Ltd. is an investment holding company, which engages in providing orthopedic surgeries, medical care, and diagnosis services. Its services include orthopedic surgeries, medical care, rehabilitative therapy, physiotherapy, non-surgical treatments, medical diagnosis, magnetic resonance imaging, general surgery, x-ray, lump removal, sports medicine, and total hip replacement. The company was founded by Man Hing Yip on August 10, 2023 and is headquartered in Singapore.